Inhibition of p73 function by Pifithrin-α as revealed by studies in zebrafish embryos

Cell Cycle

Volumn 7, Issue 9, 2008, Pages 1224-1230

  Davidson, William ^a   Ren, Qing ^a   Kari, Gabor ^a   Kashi, Ori ^a   Dicker, Adam P ^a   Rodeck, Ulrich ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Development; Pifithrin ; Radiation effects; Tumor suppressor protein p53; Tumor suppressor protein p73; Zebrafish

Indexed keywords

ANTISENSE MORPHOLINO OLIGONUCLEOTIDE; COMPLEMENTARY DNA; PIFITHRIN ALPHA; PROTEIN P53; PROTEIN P73;

ARTICLE; BRAIN; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; EMBRYO; EYE; FERTILIZATION; HEAD; IONIZING RADIATION; KIDNEY FUNCTION; LETHALITY; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIATION PROTECTION; RADIOSENSITIVITY; REPORTER GENE; VERTEBRATE; ZEBRA FISH;

DANIO RERIO; VERTEBRATA;

EID: 44349155965     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.7.9.5786     Document Type: Article

References (35)

1. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000; 408:433-9.
2. Iliakis G, Wang Y, Guan J, Wang H. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 2003; 22:5834-47.
3. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annual Review of Biochemistry 2004; 73:39-85.
4. Cimoli G, Malacarne D, Ponassi R, Valenti M, Alberti S, Parodi S. Meta-analysis of the role of p53 status in isogenic systems tested for sensitivity to cytotoxic antineoplastic drugs. Biochimica et Biophysica Acta 2004; 1705:103-20.
5. Zhu C, Bogue MA, Lim DS, Hasty P, Roth DB. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 1996; 86:379-89.
6. Nussenzweig A, Chen C, da Costa Soares V, Sanchez M, Sokol K, Nussenzweig MC, Li GC. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 1996; 382:551-5.
7. Kurimasa A, Ouyang H, Dong LJ, Wang S, Li X, Cordon-Cardo C, Chen DJ, Li GC. Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis. Proc Natl Acad Sci USA 1999; 96:1403-8.
8. Frank KM, Sekiguchi JM, Seidl KJ, Swat W, Rathbun GA, Cheng HL, Davidson L, Kangaloo L, Alt FW. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature 1998; 396:173-7.
9. Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma.[see comment]. Genes Dev 1996; 10:2411-22.
10. Brown EJ, Baltimore D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev 2000; 14:397-402.
11. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F, Bradley A, Donehower LA, Elledge SJ. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev 2000; 14:1448-59.
12. Takai H, Naka K, Okada Y, Watanabe M, Harada N, Saito S, Anderson CW, Appella E, Nakanishi M, Suzuki H, Nagashima K, Sawa H, Ikeda K, Motoyama N. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. Embo J 2002; 21:5195-205.
13. Gudkov AV, Komarova EA. The role of p53 in determining sensitivity to radiotherapy. Nature Reviews Cancer 2003; 3:117-29.
14. Irwin MS. Family feud in chemosensitvity: p73 and mutant p53. Cell Cycle 2004; 3:319-23.
15. Rubinstein AL. Zebrafish: from disease modeling to drug discovery. Current Opinion in Drug Discovery & Development 2003; 6:218-23.
16. McAleer MF, Davidson C, Davidson WR, Yentzer B, Farber SA, Rodeck U, Dicker AP. Novel use of zebrafish as a vertebrate model to screen radiation protectors and sensitizers. International Journal of Radiation Oncology, Biology, Physics 2005; 61:10-3.
17. Heasman J. Morpholino oligos: making sense of antisense? Developmental Biology 2002; 243:209-14.
18. Daroczi B, Kari G, McAleer MF, Wolf JC, Rodeck U, Dicker AP. In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model. Clin Cancer Res 2006; 12:7086-91.
19. Berghmans S, Murphey RD, Wienholds E, Neuberg D, Kutok JL, Fletcher CD, Morris JP, Liu TX, Schulte Merker S, Kanki JP, Plasterk R, Zon LI, Look AT. tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc Natl Acad Sci USA 2005; 102:407-12.
20. Langheinrich U, Hennen E, Stott G, Vacun G. Zebrafish as a model organism for the identification and characterization of drugs and genes affecting p53 signaling. Curr Biol 2002; 12:2023-8.
21. Duffy KT, Wickstrom E. Zebrafish tp53 knockdown extends the survival of irradiated zebrafish embryos more effectively than the p53 inhibitor pifithrin-alpha. Cancer Biol Ther 2007; 6:675-8.
22. Komarov PG, Komarova EA, Kondratov RV, Christov Tselkov K, Coon JS, Chernov MV, Gudkov AV. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999; 285:1733-7.
23. Komarova EA, Neznanov N, Komarov PG, Chernov MV, Wang K, Gudkov AV. p53 inhibitor pifithrin alpha can suppress heat shock and glucocorticoid signaling pathways. J Biol Chem 2003; 278:15465-8.
24. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997; 90:809-19.
25. Rentzsch F, Kramer C, Hammerschmidt M. Specific and conserved roles of TAp73 during zebrafish development. Gene 2003; 323:19-30.
26. Satoh S, Arai K, Watanabe S. Identification of a novel splicing form of zebrafish p73 having a strong transcriptional activity. Biochem Biophys Res Commun 2004; 325:835-42.
27. Hentschel DM, Park KM, Cilenti L, Zervos AS, Drummond I, Bonventre JV. Acute renal failure in zebrafish: a novel system to study a complex disease. American Journal of Physiology - Renal Fluid & Electrolyte Physiology 2005; 288:923-9.
28. Incardona JP, Collier TK, Scholz NL. Defects in cardiac function precede morphological abnormalities in fish embryos exposed to polycyclic aromatic hydrocarbons. Toxicology & Applied Pharmacology 2004; 196:191-205.
29. Irwin MS, Kondo K, Marin MC, Cheng LS, Hahn WC, Kaelin WG Jr. Chemosensitivity linked to p73 function. Cancer Cell 2003; 3:403-10.
30. Urist M, Tanaka T, Poyurovsky MV, Prives C. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2. Genes Dev 2004; 18:3041-54.
31. Melino G. p73, the "assistant" guardian of the genome? Annals of the New York Academy of Sciences 2003; 1010:9-15.
32. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of embryonic development of the zebrafish. Dev Dyn 1995; 203:253-310.
33. Westerfield M. The zebrafish book. University of Oregon Press, Eugene OR 1995.
34. Neuhauss SC, Solnica Krezel L, Schier AF, Zwartkruis F, Stemple DL, Malicki J, Abdelilah S, Stainier DY, Driever W. Mutations affecting craniofacial development in zebrafish. Development 1996; 123:357-67.
35. Jost M, Kari C, Rodeck U. An episomal vector for stable tetracycline-regulated gene expression. Nucleic Acids Res 31(4):e15 1997; 25:3131-4.